|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 19/00 | |
| C12N 15/62 | |||
| C12N 15/867 | |||
| C12N 5/10 | |||
| A61K 48/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3170842 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15821331.4 |
| Europos patento paraiškos padavimo data | 2015-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/084023 |
| Data | 2015-07-15 |
| (87) | Numeris | WO 2016/008405 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201410341504 | 2014-07-17 | CN |
| (72) |
WANG, Huamao, CN
SONG, Bo, CN
CAI, Xiumei, CN
|
| (73) |
CAFA THERAPEUTICS LIMITED ,
2/3 Exchange Place
I.F.S.C., Dublin D01 AE27,
IE
|
| (54) | IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METHOD AND USE THEREOF |
| IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METHOD AND USE THEREOF |